Investigation Overview
May 13, 2013 (Shareholders Foundation) - An investigation on behalf of current long-term stockholders of shares of Orexigen Therapeutics, Inc. (NASDAQ:OREX) was announced concerning whether certain Orexigen Therapeutics officers and directors possibly breached their fiduciary duties in connection with certain statements. The investigation by a law firm concerns whether certain Orexig...
You must register (for free) or login to view the entire investigation.